<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Glover Burns | Activity</title>
	<link>https://toxicdolls.com/members/marybobcat43/activity/</link>
	<atom:link href="https://toxicdolls.com/members/marybobcat43/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Glover Burns.</description>
	<lastBuildDate>Sat, 02 May 2026 12:18:40 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">5c775ce75f60d33d22b868d25fc709f5</guid>
				<title>Glover Burns posted an update: Today, the increasing rate of cancer-related mortality, has [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/4474/</link>
				<pubDate>Fri, 20 Jun 2025 07:20:38 +0000</pubDate>

									<content:encoded><![CDATA[<p>Today, the increasing rate of cancer-related mortality, has rendered cancer a major global challenge, and the second leading cause of death worldwide. Conventional approaches in the treatment of cancer mainly include chemotherapy, surgery, immunotherapy, and radiotherapy. However, these approaches still come with certain disadvantages, including&hellip;<span class="activity-read-more" id="activity-read-more-4474"><a href="https://toxicdolls.com/activity-2/p/4474/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c9f70217f0511914e0756873f5d37ed4</guid>
				<title>Glover Burns became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/4465/</link>
				<pubDate>Fri, 20 Jun 2025 07:15:49 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>